Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer
about
Targeting Taxanes to Castration-Resistant Prostate Cancer Cells by Nanobubbles and Extracorporeal Shock Waves.Androgen receptor splice variants and prostate cancer: From bench to bedside.Low vitamin D status is associated with inflammation in patients with prostate cancerAndrogen-induced lncRNA POTEF-AS1 regulates apoptosis-related pathway to facilitate cell survival in prostate cancer cells.Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells.Combination of Arsenic trioxide and Everolimus (Rad001) synergistically induces both autophagy and apoptosis in prostate cancer cellsCaspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients.Transient exposure to androgens induces a remarkable self-sustained quiescent state in dispersed prostate cancer cells.Phosphorylation-induced conformational dynamics in an intrinsically disordered protein and potential role in phenotypic heterogeneity.The role of glucocorticoid receptor in prostate cancer progression: from bench to bedside.The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer.Clinical relevance of androgen receptor alterations in prostate cancer.Estrogen receptor β, a regulator of androgen receptor signaling in the mouse ventral prostate.Androgen and estrogen sensitivity of bird song: a comparative view on gene regulatory levels.Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer.Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells.Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer.Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control.Activation of Notch pathway is linked with epithelial-mesenchymal transition in prostate cancer cells.Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity.Recent Advances in Prostate Cancer Treatment and Drug Discovery.Androgen Receptor-CaMKK2 Axis in Prostate Cancer and Bone Microenvironment.Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases
P2860
Q28555163-F1DD98B7-91F0-49DF-92D8-128D685721D8Q33567024-9FD31D32-89BC-4D53-BBDB-78DC4FEEB385Q33591811-D826671A-6BE9-4B52-A1AB-5174A543D16FQ37735619-14BF5916-0A4F-4368-9BAF-37C399FFF3F9Q38697766-B3F53C4F-7C93-4BD7-8D2E-90458A9B123CQ38722639-CC30B3A9-DF9C-4969-AD06-FFC3427702FCQ38750783-A2E5D131-9D3C-4352-AB0D-E12C0E9050C0Q38828800-27203637-9A1F-420A-B4A6-965662B91B29Q38910392-44A36801-F94A-47E0-9892-8346A56F89DEQ39041932-C5FF16E8-09F9-434B-A575-088EDE8ABB3DQ39231548-48A31875-100E-4C7B-A9E8-033A3690BEE1Q42377108-E6D6A1E0-BA4E-4641-BE86-B99207C7729BQ42508857-89F9B5A8-C2B1-4BED-8964-697598B0DD7CQ46247171-B655B0D4-4788-40DC-BFC8-3C5EFAEBAF49Q47111629-54ED186D-AA43-4236-BF8E-CC7748396506Q47435335-A07B8147-EFA4-4968-B675-C455A25D85CAQ52565489-0D3AAD2C-E044-4649-A352-7D8A36A634B4Q52674354-75E4A9D0-95D6-471A-8F09-2BF0001EF64FQ52777816-A8991DF1-EFC5-4D14-8717-446D9E6E0851Q53078069-4D953EF0-0833-4002-B855-BC65543B0664Q54111821-5F23E71C-D1E9-481F-88E5-56C8089C68DEQ55500622-D55C7E75-69F2-4FD0-9E33-2E45AEF7F1FFQ57109618-C375A742-216E-4CB9-A073-02F6D82B8279
P2860
Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Molecular mechanisms underlyin ...... ion therapy in prostate cancer
@ast
Molecular mechanisms underlyin ...... ion therapy in prostate cancer
@en
Molecular mechanisms underlyin ...... ion therapy in prostate cancer
@nl
type
label
Molecular mechanisms underlyin ...... ion therapy in prostate cancer
@ast
Molecular mechanisms underlyin ...... ion therapy in prostate cancer
@en
Molecular mechanisms underlyin ...... ion therapy in prostate cancer
@nl
prefLabel
Molecular mechanisms underlyin ...... ion therapy in prostate cancer
@ast
Molecular mechanisms underlyin ...... ion therapy in prostate cancer
@en
Molecular mechanisms underlyin ...... ion therapy in prostate cancer
@nl
P2860
P921
P356
P1433
P1476
Molecular mechanisms underlyin ...... ion therapy in prostate cancer
@en
P2093
Shahriar Koochekpour
P2860
P304
64447-64470
P356
10.18632/ONCOTARGET.10901
P407
P5008
P577
2016-07-28T00:00:00Z
2016-09-27T00:00:00Z